Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen Identifies Issue with Patient Access to PCSK9 Inhibitor
Amgen Identifies Issue with Patient Access to PCSK9 Inhibitor
Amgen Identifies Issue with Patient Access to PCSK9 Inhibitor
Submitted by
admin
on March 23, 2017 - 10:13pm
Source:
Xtalks
News Tags:
Amgen
patients
PCSK9 inhibitors
Repatha
Headline:
Amgen Identifies Issue with Patient Access to PCSK9 Inhibitor
Do Not Allow Advertisers to Use My Personal information
